Sign Out
Adults and Pediatrics (aged 7-17 years): The safety and effectiveness of bromocriptine in pediatric patients has only been established for the Prolactinomas and Acromegaly indications, in pediatrics aged 7-17 years.
Prolactinomas: Conservative treatment of prolactin-secreting pituitary micro- or macro-adenomas; Prior to surgery in order to reduce tumour size and to facilitate removal; After surgery if prolactin level is still elevated.
Acromegaly: As an adjunct, or in special cases as an alternative, to surgery or radiotherapy.
Adults: Parkinson's disease: All stages of idiopathic and postencephalitic Parkinson's disease, either as monotherapy or in combination with other antiparkinsonian drugs.
Hyperprolactinaemia in men: Prolactin-related hypogonadism: Anovulatory cycles (supplementary to anti-estrogen, e.g. clomiphene).
